Vident Advisory’s Astrana Health ASTH Stock Holding History

Vident Advisory’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$826K	Sell	17,799 -5,136	-22%	-$185K	0.01%	1080
2026 Q1	$562K	Buy	+22,935	New	+$543K	﹤0.01%	1191

Other funds holding ASTH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

325 Capital New York $419M AUM 75.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vident Advisory's ASTH Position: Q2 2026 in Review

Vident Advisory reduced its Astrana Health (ASTH) stake by 22% in Q2 2026, selling an estimated $185K and leaving 17,799 shares worth $826K. The position accounts for 0.01% of the portfolio, ranked #1080.

Vident Advisory first reported a position in ASTH in Q1 2026 and has held it in 2 quarters since. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

Vident Advisory held 17,799 shares of Astrana Health worth $826K as of Q2 2026.
Vident Advisory sold 5,136 Astrana Health shares in Q2 2026, an estimated $185K.
Astrana Health made up 0.01% of Vident Advisory's portfolio in Q2 2026, its #1080 holding.
Vident Advisory first reported a position in Astrana Health in Q1 2026 and has held it in 2 quarters since.
209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.